SCHEMBL5133210

SCHEMBL5133210

COc1ccc(Cn2c(-c3csc(-c4ccc(OC)cc4)n3)cc(OC(=O)NCC3CCCCC3)c2C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 2/20 0.43
CDC25B P30305 2/20 0.43
CDC25C P30307 2/20 0.43
DUSP3 P51452 2/20 0.43
OXTR P30559 1/20 0.42
AVPR1A P37288 1/20 0.42
AVPR1B P47901 1/20 0.42
KLKB1 P03952 1/20 0.42
FAAH O00519 2/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
ABHD6 Q9BV23 1/20 0.39
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
EIF4E P06730 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MAPT P10636 3/20 0.38
HPGD P15428 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5039914 0.93 CDC25A (0.45) CDC25ACDC25BCDC25CDUSP3OXTR
SCHEMBL5043921 0.87 KLKB1 (0.52) CDC25ACDC25BCDC25CDUSP3OXTR
SCHEMBL5046060 0.85 KLKB1 (0.43) CDC25ACDC25BCDC25CDUSP3KLKB1
SCHEMBL5048642 0.85 CDC25A (0.44) CDC25ACDC25BCDC25CDUSP3OXTR
SCHEMBL5048696 0.84 CDC25A (0.43) CDC25ACDC25BCDC25CDUSP3OXTR
SCHEMBL5046954 0.84 CDC25A (0.43) CDC25ACDC25BCDC25CDUSP3OXTR
SCHEMBL5039689 0.84 MAPT (0.43) KLKB1KDM4EALDH1A1SMN1; SMN2EIF4E
SCHEMBL5043910 0.83 CDC25A (0.45) CDC25ACDC25BCDC25CDUSP3OXTR
SCHEMBL5140692 0.83 FAAH (0.46) CDC25ACDC25BCDC25CDUSP3FAAH
SCHEMBL5044042 0.83 CDC25A (0.42) CDC25ACDC25BCDC25CDUSP3OXTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-B1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP claimed